Upgrade to SI Premium - Free Trial

Sonoma Pharmaceuticals (SNOA)

1.14 -0.07 (5.79%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/8/26 *Est.)

Latest Headlines

Form DEF 14A Sonoma Pharmaceuticals, For: Jun 24 May 5, 2026 4:55 PM - SEC Filing Form 8-K Sonoma Pharmaceuticals, For: Apr 24 April 30, 2026 5:01 PM - SEC Filing Form 424B4 Sonoma Pharmaceuticals, April 27, 2026 6:05 AM - SEC Filing Form PRE 14A Sonoma Pharmaceuticals, For: Apr 24 April 27, 2026 6:04 AM - SEC Filing Sonoma Pharmaceuticals prices $4 million public offering at $1.35 per share April 24, 2026 9:23 AM - StreetInsider Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering April 24, 2026 9:23 AM - StreetInsider Form EFFECT Sonoma Pharmaceuticals, April 24, 2026 6:05 AM - SEC Filing Form S-1/A Sonoma Pharmaceuticals, April 23, 2026 6:05 AM - SEC Filing Form S-1 Sonoma Pharmaceuticals, April 17, 2026 5:24 PM - SEC Filing Form 8-K Sonoma Pharmaceuticals, For: Apr 08 April 9, 2026 8:31 AM - SEC Filing Sonoma Pharmaceuticals launches burn relief hydrogel in CVS and Walmart March 24, 2026 8:33 AM - StreetInsider Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart March 24, 2026 8:30 AM - StreetInsider Sonoma Pharmaceuticals launches Aquanil AD skin care line March 18, 2026 8:32 AM - StreetInsider Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin March 18, 2026 8:31 AM - StreetInsider Full Article List